Cart 0

MarketsandMarkets

Proteomics Market- Forecast to 2021

$5,650.00

Report Published By: MarketsandMarkets
Publication Date : Dec-16
No. Of Pages: 269

The global proteomics market is projected to reach USD 21.87 billion by 2021, at a CAGR of 11.7% during the forecast period of 2016 to 2021. Growth in this market is majorly driven by the rising acceptance of personalized medicines, increasing pharmaceutical and biotechnology R&D funding supporting proteomics research across the globe, and shift in focus from genomics to proteomics.

The global proteomics market is segmented on the basis of instrumentation technology, reagent, services & software, application, and region. Based on instrumentation technology, the proteomics market is broadly segmented into protein microarray, spectroscopy, X-ray crystallography, chromatography, electrophoresis, surface plasmon resonance (SPR) systems, and protein fractionation systems. In 2015, the spectroscopy segment accounted for the largest share of the proteomics market. The growing preference for these technologies in clinical diagnostics over conventional methods and the ability of spectroscopy technologies to offer faster results with high sensitivity and accuracy are contributing to the growth of spectroscopy market during forecast period.

On the basis of application, the market is segmented into drug discovery, clinical diagnostics, and other applications. In 2015, the clinical diagnostics segment accounted for the largest share of the global proteomics market. The drug discovery segment is expected to register the highest CAGR during the forecast period due to the ability of proteomics in providing important information on target druggability and development of relevant therapeutic leads for drug development.

In 2015, North America commanded the largest share of the proteomics market, followed by Europe. The U.S. is a prime market for proteomics due to the rising acceptance of personalized medicines and growing focus of stakeholders on research projects involving proteins, peptides, amino acid composition, associated biomolecules, and genes in the country. The Asia-Pacific market is expected to witness the highest growth in the coming years primarily due to the growing focus of manufacturers on this region.

Major players in the global proteomics market are Agilent Technologies, Inc. (U.S.), Bio-Rad Laboratories, Inc. (U.S.), Bruker Corporation (U.S.), Danaher Corporation (U.S.), GE Healthcare (U.S.), Luminex Corporation (U.S.), Merck KGaA (Germany), PerkinElmer Inc. (U.S.), Thermo Fisher Scientific, Inc. (U.S.), and Waters Corporation (U.S.).


Research Coverage

• Detailed insights on all the submarkets, based on instrumentation technology (spectroscopy, chromatography, electrophoresis, immunoassay, HPLC, X-ray crystallography, mass spectrometry, surface plasmon resonance systems, and other technologies) this can help market players to identify high growth segments in the proteomics market

• Detailed insights on all the submarkets, based on reagent (spectroscopy reagents, chromatography reagents, electrophoresis reagents, immunoassay reagents, X-ray crystallography reagents, microarray reagents, and protein fractionation reagents) this can help market players to identify high growth segments in the proteomics market

• Detailed insights on all the submarkets, based on services & software (analytical laboratory services, data analysis & maintenance, and quantitation services) this can help market players to identify high growth segments in the proteomics market


• The report also provides information on key players in this market and their growth strategies and recent developments. This can help the company to assess the competition at global and regional levels in a better manner


• Key insights and market sizing for the different applications of the proteomics market, namely, drug discovery, diagnostics, and other applications

• Country-wise market size and forecast for all the subsegments. Thus, not only the high growth technologies, reagent, services & software, and application areas; the market size numbers provided in the report will also enable market players to identify key geographic markets, and thereby strategize global marketing efforts in order to achieve sustainable revenue growth in the coming years

• It provides key insights on market dynamics, such as drivers, restraints, opportunities, and challenges for this market


Reasons to Buy the Report
The report will enrich established firms as well as new entrants/smaller firms to gauge the pulse of the market, which in turn would help them garner a greater market share. Firms purchasing the report could use one or a combination of the below-mentioned five strategies for increasing their market shares.

This report provides insights on the following pointers:
• Market Penetration: Comprehensive information on the product portfolios offered by top players in the proteomics market. The report analyzes the market by instrumentation technology, reagent, services & software, application, and region
• Product Development/Innovation: Detailed insights on upcoming trends, R&D activities, and new product launches in the proteomics market
• Market Development: Comprehensive information on lucrative emerging markets. The report analyzes the markets for proteomics across geographies
• Market Diversification: Exhaustive information about new products, growing regions, recent developments, and investments in the proteomics market
• Competitive Assessment: In-depth assessment of market shares, growth strategies, products, distribution networks, and manufacturing capabilities of leading players in the proteomics market

TABLE OF CONTENTS

1 INTRODUCTION 20
1.1 OBJECTIVES OF THE STUDY 20
1.2 MARKET DEFINITION 20
1.2.1 MARKETS COVERED 21
1.2.2 YEARS CONSIDERED FOR THE STUDY 21
1.3 CURRENCY 22
1.4 LIMITATIONS 22
1.5 STAKEHOLDERS 22
2 RESEARCH METHODOLOGY 23
2.1 RESEARCH APPROACH 23
2.1.1 SECONDARY DATA 24
2.1.1.1 Key data from secondary sources 24
2.1.2 PRIMARY DATA 25
2.1.2.1 Key data from primary sources 25
2.1.2.2 Key industry insights 26
2.2 MARKET SIZE ESTIMATION 26
2.3 MARKET BREAKDOWN AND DATA TRIANGULATION 28
2.4 MARKET SHARE ESTIMATION 29
2.5 ASSUMPTIONS FOR THE STUDY 29
3 EXECUTIVE SUMMARY 30
4 PREMIUM INSIGHTS 36
4.1 GLOBAL PROTEOMICS MARKET OVERVIEW 36
4.2 ASIA-PACIFIC: PROTEOMICS MARKET SHARE, BY APPLICATION (2015) 37
4.3 GEOGRAPHIC SNAPSHOT OF THE PROTEOMICS MARKET 38
4.4 GEOGRAPHIC MIX: PROTEOMICS MARKET 38
4.5 PROTEOMICS MARKET: DEVELOPED VS. DEVELOPING COUNTRIES 39
5 MARKET OVERVIEW 40
5.1 INTRODUCTION 41
5.2 KEY MARKET DYNAMICS 42
5.2.1 KEY MARKET DRIVERS 43
5.2.1.1 Increasing demand for personalized medicine 43
5.2.1.2 Proteomics bridges the gap between genome sequence and cellular behavior 43
5.2.1.3 Increasing pharmaceutical and biotech r&d expenditure 43
?
5.2.1.4 Technological advancements 44
5.2.1.5 Availability of government and private funding 45
5.2.2 KEY MARKET RESTRAINTS 45
5.2.2.1 Sequestration cuts in the U.S. and reduced funds for proteomic research 45
5.2.2.2 Huge disconnect between biomarker discovery and biomarker approval by regulatory authorities 46
5.2.2.3 Expensive tools and instruments and their maintenance 46
5.2.3 KEY MARKET OPPORTUNITIES 47
5.2.3.1 Growing applications of nanotechnology 47
5.2.3.2 Biomarker identification 47
5.2.3.3 Untapped emerging markets 47
5.2.4 KEY MARKET CHALLENGES 48
5.2.4.1 Managing large volumes of data generated in proteomics research 48
5.2.4.2 Dearth of skilled researchers and mandatory training cost 48
6 INDUSTRY INSIGHTS 49
6.1 INTRODUCTION 49
6.2 INDUSTRY TRENDS 49
6.2.1 SHIFT FROM GENOMICS TO PROTEOMICS 50
6.2.2 GROWING NUMBER OF COLLABORATIONS IN PROTEOMICS MARKET 50
6.3 PRODUCT PORTFOLIO ANALYSIS 51
6.4 REGULATORY ANALYSIS 53
6.4.1 NORTH AMERICA 53
7 GLOBAL PROTEOMICS MARKET, BY INSTRUMENTATION TECHNOLOGY 54
7.1 INTRODUCTION 55
7.2 PROTEIN MICROARRAYS 57
7.2.1 BIOCHIPS 58
7.2.1.1 Protein chips 60
7.2.1.2 Lab-on-chips (microfluidics) 61
7.2.2 MICROARRAY INSTRUMENTS 63
7.2.2.1 Integrated systems 64
7.2.2.2 Arrayers 64
7.2.2.3 Microarray scanners 65
7.3 SPECTROSCOPY 66
7.3.1 MASS SPECTROMETRY 68
7.3.2 NMR SPECTROSCOPY 69
7.3.3 CD SPECTROSCOPY 70
7.4 X-RAY CRYSTALLOGRAPHY 72
7.5 CHROMATOGRAPHY 73
7.5.1 HPLC 75
7.5.2 ION CHROMATOGRAPHY 76
7.5.3 AFFINITY CHROMATOGRAPHY 77
7.5.4 SUPERCRITICAL FLUID CHROMATOGRAPHY 78
7.6 ELECTROPHORESIS 79
7.6.1 GEL ELECTROPHORESIS 81
7.6.2 CAPILLARY ELECTROPHORESIS 82
7.7 SURFACE PLASMON RESONANCE (SPR) 83
7.8 PROTEIN FRACTIONATION 84
8 GLOBAL PROTEOMICS MARKET, BY REAGENT 86
8.1 INTRODUCTION 87
8.2 PROTEIN MICROARRAY REAGENTS 89
8.3 SPECTROSCOPY REAGENTS 90
8.4 X-RAY CRYSTALLOGRAPHY REAGENTS 91
8.5 CHROMATOGRAPHY REAGENTS 92
8.6 ELECTROPHORESIS REAGENTS 93
8.7 IMMUNOASSAY REAGENTS 94
8.8 PROTEIN FRACTIONATION REAGENTS 95
9 GLOBAL PROTEOMICS MARKET, BY SERVICES AND SOFTWARE 96
9.1 INTRODUCTION 97
9.2 ANALYTICAL LABORATORY SERVICES 99
9.2.1 PROTEIN IDENTIFICATION 100
9.2.2 PROTEIN SEPARATION 102
9.2.3 PROTEIN SEQUENCING 103
9.3 DATA ANALYSIS & MAINTENANCE 104
9.3.1 BIOINFORMATICS DATABASES 105
9.3.2 BIOINFORMATICS TOOLS 106
9.4 QUANTITATION SERVICES 107
10 GLOBAL PROTEOMICS MARKET, BY APPLICATION 109
10.1 INTRODUCTION 110
10.2 DRUG DISCOVERY 111
10.3 CLINICAL DIAGNOSTICS 113
10.4 OTHER PROTEOMICS APPLICATIONS 115
11 GLOBAL PROTEOMICS MARKET, BY REGION 116
11.1 INTRODUCTION 117
11.2 NORTH AMERICA 118
11.2.1 U.S. 122
11.2.2 CANADA 125
?
11.3 EUROPE 128
11.3.1 GERMANY 132
11.3.2 FRANCE 135
11.3.3 ITALY 138
11.3.4 U.K. 140
11.3.5 SPAIN 143
11.3.6 REST OF EUROPE (ROE) 145
11.4 ASIA-PACIFIC 147
11.4.1 CHINA 151
11.4.2 INDIA 154
11.4.3 JAPAN 156
11.4.4 REST OF ASIA-PACIFIC 158
11.5 LATIN AMERICA 161
11.5.1 BRAZIL 164
11.5.2 MEXICO 166
11.5.3 REST OF LATIN AMERICA 168
11.6 MIDDLE EAST AND AFRICA 170
12 COMPETITIVE LANDSCAPE 173
12.1 OVERVIEW 173
12.2 STRATEGIC BENCHMARKING 175
12.2.1 INCREASING FOCUS ON PRODUCT LAUNCHES AND ENHANCEMENTS 175
12.3 MARKET RANKING ANALYSIS 177
12.3.1 PROTEOMIC INSTRUMENTATION TECHNOLOGY 177
12.3.2 PROTEOMIC REAGENTS 178
12.3.3 PROTEOMICS SERVICES AND SOFTWARE 178
12.4 COMPETITIVE SITUATIONS AND TRENDS 180
12.4.1 PRODUCT LAUNCHES AND ENHANCEMENTS 181
12.4.2 PARTNERSHIPS, AGREEMENTS, COLLABORATIONS, AND ALLIANCES 182
12.4.3 ACQUISITIONS 183
12.4.4 EXPANSIONS 184
13 COMPANY PROFILES 185
(Overview, Products and Services, Financials, Strategy & Development)*
13.1 INTRODUCTION 185
13.2 THERMO FISHER SCIENTIFIC, INC. 186
13.3 AGILENT TECHNOLOGIES, INC. 192
13.4 BIO-RAD LABORATORIES, INC. 197
13.5 MERCK KGAA 202
13.6 DANAHER CORPORATION 210
13.7 LUMINEX CORPORATION 216
13.8 PERKINELMER, INC. 218
13.9 WATERS CORPORATION 223
13.10 GE HEALTHCARE 227
13.11 BRUKER CORPORATION 232
*Details on Overview, Products and Services, Financials, Strategy & Development might not be Captured in case of Unlisted Companies.
14 APPENDIX 239
14.1 INSIGHTS OF INDUSTRY EXPERTS 239
14.2 DISCUSSION GUIDE 240
14.3 OTHER DEVELOPMENTS 246
14.4 KNOWLEDGE STORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL 260
14.5 INTRODUCING RT: REAL-TIME MARKET INTELLIGENCE 262
14.6 AVAILABLE CUSTOMIZATIONS 264
14.7 RELATED REPORTS 265
14.8 AUTHOR DETAILS 266

* indicates required information

* indicates required information


Share this Product


More from this collection